Genentech, Inc

(NYSE:DNA)

71.80

-4.80 (-6.27%)

Dec 01 - Close

Open
75.35
High
75.38
Low
71.17
Vol.
4.99M
Mkt Cap
80.59B
52Wk High
99.14
52Wk Low
65.35
Avg. Vol.
4.73M
P/E (Trailing)
24.58
Beta
0.39
Short %
0.40%
Div. Yield

After-Hours 72.50 +0.70 (0.97%) Mon, 1 Dec 2008 6:50 PM

Company Profile

Genentech, Inc

One DNA Way

South San Francisco, CA 94080-4990

United States - Map

Phone: (650) 225-4150

Fax: (650) 225-8326

Website: www.gene.com

State of incorporation: Delaware

CEO: Dr. Arthur D. Levinson, Ph.D.

Employees: 11,174

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Dev/manu/mkt human pharmaceuticals

A biotechnology company which discovers, develops and manufactures pharmaceutical products to treat patients with medical needs.

Recent news for DNA

Recent opinions on DNA

No recent Opinions for DNA

Top members owning DNA

  • Top 66%

    JasonK

    JasonK

    -43.04%3m:

    -47.67%YTD:

  • Top 4%

    jasonk2

    jasonk2

    -31.91%3m:

    -14.14%YTD:

  • Top 48%

    mcara527

    mcara527

    -34.41%3m:

    -33.42%YTD:

Members owning DNA also own

GOOG (36.84%), JNJ (36.84%), GE (31.58%), JPM (31.58%), IBM (26.32%)

Member sentiment: Neutral